Literature DB >> 7795810

Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin.

B Loun1, D S Hage.   

Abstract

High-performance affinity chromatography was used to examine the binding of thyroid hormones and related compounds at the warfarin and indole sites of human serum albumin (HSA). This was studied by continuously applying L-triiodothyronine (L-T3), L-reverse triiodothyronine (L-rT3) or structural analogs of these compounds to an immobilized HSA column while making injections of site-specific probe molecules (i.e. R-warfarin and L-tryptophan). The results were compared with those obtained previously for L-thyroxine (L-T4). Equilibrium association constants and thermodynamic parameters measured by this approach showed good agreement with previous models reported for L-T4 and L-T3 at their high-affinity sites on HSA. This data confirmed that the phenol groups of L-T4 and L-T3 played a significant role in the binding of these compounds at the indole site. Work performed at the warfarin site and with other solutes (e.g. L-rT3) indicated that additional factors, such as interactions through the thyronine backbone or terminal amine and carboxyl groups of these compounds, could also be involved in the binding of thyroid hormones to HSA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795810     DOI: 10.1016/0378-4347(94)00547-i

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  16 in total

1.  High-performance frontal analysis of the binding of thyroxine enantiomers to human serum albumin.

Authors:  Tomoko Kimura; Keiko Nakanishi; Terumichi Nakagawa; Akimasa Shibukawa; Katsumi Matsuzaki
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

Review 2.  Analysis of solute-protein interactions and solute-solute competition by zonal elution affinity chromatography.

Authors:  Pingyang Tao; Saumen Poddar; Zuchen Sun; David S Hage; Jianzhong Chen
Journal:  Methods       Date:  2018-02-02       Impact factor: 3.608

Review 3.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

4.  Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography.

Authors:  Hai Xuan; K S Joseph; Chunling Wa; David S Hage
Journal:  J Sep Sci       Date:  2010-08       Impact factor: 3.645

5.  Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent.

Authors:  John Vargas-Badilla; Saumen Poddar; Shiden Azaria; Chenhua Zhang; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-05-04       Impact factor: 3.205

Review 6.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

Review 7.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

Review 8.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

9.  The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery.

Authors:  Vacis Tatarunas; Vaiva Lesauskaite; Audrone Veikutiene; Pranas Grybauskas; Povilas Jakuska; Laima Jankauskiene; Ruta Bartuseviciute; Rimantas Benetis
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

10.  Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia.

Authors:  Isabelle Petitpas; Charles E Petersen; Chung-Eun Ha; Ananyo A Bhattacharya; Patricia A Zunszain; Jamie Ghuman; Nadhipuram V Bhagavan; Stephen Curry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.